yy-20394

Relapsed or Refractory Peripheral T-Cell Lymphoma

Shanghai YingLi Pharmaceutical Co. Ltd.Phase 1

—

Rating in progress

yy-20394 in Relapsed or Refractory Peripheral T-Cell Lymphoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Dormant